Cysteinylation of MHC Class II Ligands: Peptide Endocytosis and Reduction Within APC Influences T Cell Recognition1
暂无分享,去创建一个
[1] Y. Ishii,et al. Posttranslational modification of the glycosylation inhibiting factor (GIF) gene product generates bioactive GIF. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[2] J. Blum,et al. Endocytic Recycling is Required for the Presentation of an Exogenous Peptide via MHC Class II Molecules , 2000, Traffic.
[3] E. Sercarz,et al. Processing and Reactivity of T Cell Epitopes Containing Two Cysteine Residues from Hen Egg-White Lysozyme (HEL74–90)1 , 2000, The Journal of Immunology.
[4] P. Cresswell,et al. Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT). , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[5] J. Strominger,et al. Extracellular antigen processing and presentation by immature dendritic cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[6] D. Zaller,et al. Role of APC in the selection of immunodominant T cell epitopes. , 1999, Journal of immunology.
[7] J. Shabanowitz,et al. Cutting edge: the HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique. , 1999, Journal of immunology.
[8] C. Walsh,et al. Tandem heterocyclization activity of the multidomain 230 kDa HMWP2 subunit of Yersinia pestis yersiniabactin synthetase: interaction of the 1-1382 and 1383-2035 fragments. , 1999, Biochemistry.
[9] A. Rosen,et al. Cleavage by Granzyme B Is Strongly Predictive of Autoantigen Status , 1999, The Journal of experimental medicine.
[10] S. Brennan,et al. Albumin banks peninsula: a new termination variant characterised by electrospray mass spectrometry. , 1999, Biochimica et biophysica acta.
[11] R. Steinman,et al. Induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses using dendritic cells pulsed with EBNA-3A peptides or UV-inactivated, recombinant EBNA-3A vaccinia virus. , 1999, Blood.
[12] R. Steinman,et al. Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. , 1999, The Journal of clinical investigation.
[13] R. Steinman,et al. Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies. , 1999, Human immunology.
[14] J. Yewdell,et al. Modification of Cysteine Residues In Vitro and In Vivo Affects the Immunogenicity and Antigenicity of Major Histocompatibility Complex Class I–restricted Viral Determinants , 1999, The Journal of experimental medicine.
[15] K. Sakaguchi,et al. Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles. , 1998, Journal of immunology.
[16] K. Takahashi,et al. Drug-induced inhibition of insulin recognition by T-cells: the antirheumatic drug aurothiomalate inhibits MHC binding of insulin peptide. , 1998, Molecular immunology.
[17] C. Janeway,et al. Exogenously Provided Peptides of a Self-antigen Can Be Processed into Forms that Are Recognized by Self–T Cells , 1998, The Journal of experimental medicine.
[18] M F del Guercio,et al. Several common HLA-DR types share largely overlapping peptide binding repertoires. , 1998, Journal of immunology.
[19] J. Shabanowitz,et al. Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: implications for tumor vaccine development. , 1998, Journal of immunology.
[20] M. Bevan,et al. Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. , 1998, Immunity.
[21] F. Modugno,et al. MHC‐Peptide Binding: Dimers of Cysteine‐Containing Nonapeptides Bind with High Affinity to HLA‐A2.1 Class I Molecules , 1997, Journal of immunotherapy.
[22] M. Bevan,et al. Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. , 1997, Blood.
[23] C. Watts,et al. Characterization of transport of newly assembled, T cell-stimulatory MHC class II-peptide complexes from MHC class II compartments to the cell surface. , 1997, Journal of immunology.
[24] D. Pious,et al. Exogenously provided peptides fail to complex with intracellular class II molecules for presentation by antigen-presenting cells. , 1997, Journal of Immunology.
[25] M. Bevan,et al. Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL. , 1997, Journal of immunology.
[26] A. Agulnik,et al. The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. , 1997, Immunity.
[27] N. Pavletich,et al. Structure of the p53 Tumor Suppressor Bound to the Ankyrin and SH3 Domains of 53BP2 , 1996, Science.
[28] B. Evavold,et al. Enhanced Dissociation of HLA-DR-Bound Peptides in the Presence of HLA-DM , 1996, Science.
[29] Y. Chien,et al. Early biochemical signals arise from low affinity TCR-ligand reactions at the cell-cell interface , 1996, The Journal of experimental medicine.
[30] D. Fremont,et al. Structures of an MHC Class II Molecule with Covalently Bound Single Peptides , 1996, Science.
[31] D. Weber,et al. DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. , 1995, Immunity.
[32] P. Cresswell,et al. HLA-DM induces clip dissociation from MHC class II αβ dimers and facilitates peptide loading , 1995, Cell.
[33] D. Zaller,et al. Mediation by HLA-DM of dissociation of peptides from HLA-DR , 1995, Nature.
[34] Eric O Long,et al. Antigen presentation mediated by recycling of surface HLA-DR molecules , 1995, Nature.
[35] J. Wharton,et al. Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines , 1995, The Journal of experimental medicine.
[36] P. Cresswell,et al. Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles , 1995, The Journal of experimental medicine.
[37] K. McCoy,et al. Characterization of fibroblasts with a unique defect in processing antigens with disulfide bonds. , 1995, Journal of immunology.
[38] A. Rudensky,et al. Intracellular assembly and transport of endogenous peptide-MHC class II complexes. , 1994, Immunity.
[39] G. Nepom,et al. Coordinate defects in human histocompatibility leukocyte antigen class II expression and antigen presentation in bare lymphocyte syndrome , 1994, The Journal of experimental medicine.
[40] H. Ploegh,et al. Isolation and characterization of the intracellular MHC class II compartment , 1994, Nature.
[41] A. Wandinger-Ness,et al. Separation of subcellular compartments containing distinct functional forms of MHC class II , 1994, The Journal of cell biology.
[42] J. Rothbard,et al. Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401. , 1994, Journal of immunology.
[43] P. Jensen,et al. Membrane interactions influence the peptide binding behavior of DR1 , 1994, The Journal of experimental medicine.
[44] H. Geuze,et al. Immunogenic peptides bind to class II MHC molecules in an early lysosomal compartment. , 1993, Journal of immunology.
[45] J. Gariépy,et al. Characterization of the insulin A-chain major immunogenic determinant presented by MHC class II I-Ad molecules. , 1993, Journal of immunology.
[46] P. Højrup,et al. Amino acid exchange and covalent modification by cysteine and glutathione explain isoforms of fatty acid-binding protein occurring in bovine liver. , 1993, The Journal of biological chemistry.
[47] K. Magnusson,et al. Microtubules are involved in transport of macromolecules by vesicles in cultured bovine aortic endothelial cells , 1993, Journal of cellular physiology.
[48] P. Jensen,et al. Acidification and disulfide reduction can be sufficient to allow intact proteins to bind class II MHC. , 1993, Journal of immunology.
[49] L. Otvos,et al. Posttranslational side chain modification of a viral epitope results in diminished recognition by specific T cells , 1992, Journal of virology.
[50] A Sette,et al. Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. , 1992, Science.
[51] E. Unanue,et al. Reduction of disulfide bonds within lysosomes is a key step in antigen processing. , 1991, Journal of immunology.
[52] P. Jensen. Reduction of disulfide bonds during antigen processing: evidence from a thiol-dependent insulin determinant , 1991, The Journal of experimental medicine.
[53] P. Jensen,et al. Enhanced binding of peptide antigen to purified class II major histocompatibility glycoproteins at acidic pH , 1991, The Journal of experimental medicine.
[54] A. Rudensky,et al. Sequence analysis of peptides bound to MHC class II molecules , 1991, Nature.
[55] R. Germain,et al. MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding , 1991, Nature.
[56] J. Berzofsky,et al. Recognition of peptides that are immunopathogenic but cryptic. Mechanisms that allow lymphocytes sensitized against cryptic peptides to initiate pathogenic autoimmune processes. , 1991, Journal of immunology.
[57] J. Hansen,et al. Structural requirements for recognition of the HLA-Dw14 class II epitope: a key HLA determinant associated with rheumatoid arthritis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[58] Emil R. Unanue,et al. Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation , 1990, Nature.
[59] G. Ferrara,et al. Binding of labelled influenza matrix peptide to HLA DR in living B lymphoid cells , 1989, Nature.
[60] M. Bevan,et al. Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization , 1989, The Journal of experimental medicine.
[61] P. Allen,et al. Binding to Ia protects an immunogenic peptide from proteolytic degradation. , 1989, Journal of immunology.
[62] C. Granier,et al. Processing by accessory cells for presentation to murine T cells of apamin, a disulfide-bonded 18 amino acid peptide. , 1988, Journal of immunology.
[63] R. Germain,et al. Processing of a minimal antigenic peptide alters its interaction with MHC molecules , 1988, Nature.
[64] B. Singh,et al. Processing and presentation of insulin. I. Analysis of immunogenic peptides and processing requirements for insulin A loop-specific T cells. , 1987, Journal of immunology.
[65] H. Geuze,et al. Sorting of endocytosed transferrin and asialoglycoprotein occurs immediately after internalization in HepG2 cells , 1987, The Journal of cell biology.
[66] B. Storrie,et al. Effects of temperature, pH elevators, and energy production inhibitors on horseradish peroxidase transport through endocytic vesicles , 1987, Journal of cellular physiology.
[67] A Sette,et al. The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides , 1987, Science.
[68] A. Hubbard,et al. Receptor-mediated endocytosis of epidermal growth factor by rat hepatocytes: receptor pathway , 1986, The Journal of cell biology.
[69] A. Bolognesi,et al. Recycling of the asialoglycoprotein receptor and the effect of lysosomotropic amines in hepatoma cells , 1984, The Journal of cell biology.
[70] H. Grey,et al. Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing , 1983, The Journal of experimental medicine.
[71] P. Weigel,et al. Endocytosis and degradation mediated by the asialoglycoprotein receptor in isolated rat hepatocytes. , 1982, The Journal of biological chemistry.
[72] P. Marrack,et al. Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition , 1981, The Journal of experimental medicine.
[73] C. Watts,et al. Capture and processing of exogenous antigens for presentation on MHC molecules. , 1997, Annual review of immunology.
[74] R. Germain,et al. Extensive trafficking of MHC class II-invariant chain complexes in the endocytic pathway and appearance of peptide-loaded class II in multiple compartments. , 1995, Immunity.
[75] I Mellman,et al. Acidification of the endocytic and exocytic pathways. , 1986, Annual review of biochemistry.